COO and Whole Time Director resigns effective Dec 31, 2025

Key managerial personnel resignedManagement Changes View source PDF Explain this filing

SOLARA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.2%Reaction day

₹550.05

prior close

₹545.80

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.4%+1.2% vs market

Pharmaceuticals peers, median of 156sector-2.0%+0.8% vs sector

On the reaction day the stock moved 1.2 pts more than Nifty Microcap 250 and 0.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.3

10m

+0.7

15m

+1.5

30m

+1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.2-2.4+1.2-2.0+0.8

Next day

+9.4-0.4+9.9-1.4+10.8

+11.2-1.1+12.2-1.4+12.6

+8.4-0.6+9.0-1.0+9.4

+7.1-0.4+7.5-0.8+8.0

+7.5+0.1+7.3-0.6+8.0

+7.2-1.4+8.6-2.1+9.3

15d

+0.1-1.0+1.1-2.1+2.1

+1.4-0.8+2.1-1.4+2.8

-13.1-0.9-12.2-5.0-8.1

-17.6-11.3-6.4-10.8-6.8

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Mohan Muthunarayanan has resigned as Whole Time Director and Chief Operating Officer of Solara Active Pharma Sciences, effective end of business hours on December 31, 2025. He is moving to a new role as COO of Synthix Global Pharma Solutions Limited, a wholly owned subsidiary, where he will focus on developing the Polymers and CRAMs division and converting the Vizag facility into a CDMO facility. No other material reasons were cited.

Likely market impact

Internal leadership reshuffle within the Solara group; no disruption to parent company operations as the executive continues within a subsidiary.